Herbalife Ltd. (NYSE:HLF - Get Free Report) shares were down 3.9% during trading on Tuesday . The stock traded as low as $7.36 and last traded at $7.40. Approximately 130,393 shares were traded during trading, a decline of 94% from the average daily volume of 2,234,802 shares. The stock had previously closed at $7.70.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on the stock. Citigroup reduced their price target on shares of Herbalife from $13.00 to $11.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. DA Davidson raised shares of Herbalife from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $7.50 to $14.00 in a research note on Friday, March 21st. Finally, Wall Street Zen raised Herbalife from a "hold" rating to a "buy" rating in a research note on Friday, May 30th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, Herbalife currently has an average rating of "Moderate Buy" and an average price target of $11.50.
Check Out Our Latest Analysis on Herbalife
Herbalife Stock Performance
The firm has a market capitalization of $781.17 million, a P/E ratio of 3.08, a PEG ratio of 0.29 and a beta of 0.88. The firm has a 50 day simple moving average of $7.17 and a two-hundred day simple moving average of $7.19.
Herbalife (NYSE:HLF - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The company reported $0.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.19. The business had revenue of $1.22 billion during the quarter, compared to the consensus estimate of $1.23 billion. Herbalife had a net margin of 5.09% and a negative return on equity of 20.78%. The firm's quarterly revenue was down 3.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.49 EPS. Sell-side analysts anticipate that Herbalife Ltd. will post 1.57 earnings per share for the current year.
Insider Buying and Selling at Herbalife
In other news, Director Juan Miguel Mendoza acquired 5,000 shares of Herbalife stock in a transaction that occurred on Thursday, May 22nd. The stock was bought at an average price of $6.75 per share, with a total value of $33,750.00. Following the completion of the purchase, the director now owns 166,857 shares in the company, valued at approximately $1,126,284.75. The trade was a 3.09% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.73% of the company's stock.
Institutional Investors Weigh In On Herbalife
Large investors have recently added to or reduced their stakes in the business. Rhumbline Advisers boosted its position in shares of Herbalife by 4.1% during the 1st quarter. Rhumbline Advisers now owns 152,987 shares of the company's stock valued at $1,320,000 after acquiring an additional 6,081 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Herbalife by 3.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 210,904 shares of the company's stock worth $1,820,000 after buying an additional 6,747 shares in the last quarter. Empowered Funds LLC increased its holdings in shares of Herbalife by 12.9% in the 1st quarter. Empowered Funds LLC now owns 30,301 shares of the company's stock worth $261,000 after buying an additional 3,474 shares during the last quarter. Tenzing Global Management LLC purchased a new stake in shares of Herbalife during the 1st quarter valued at $6,904,000. Finally, Parallax Volatility Advisers L.P. bought a new stake in shares of Herbalife during the 1st quarter worth $790,000.
About Herbalife
(
Get Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Further Reading
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
